Trial · NCT02583698
Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices
NCT02583698, Not applicable, Completed, Institute of Liver and Biliary Sciences, India
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices. Trials, record NCT02583698. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02583698
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices
- NCT number
- NCT02583698
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 136 participants, actual
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Conditions
- Acute on Chronic Liver Failure
- Interventions
- Carvedilol, Placebo
- First posted
- 2015-10-22
- Last updated
- 2019-06-04
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mortality in both groups | 28 days | |
| Secondary | Number of patients with development or progression of esophageal varices in both groups. | 3 Months | |
| Secondary | Number of patients with reduction in hepatic venous pressure gradient (HVPG) in both groups. | 3 Months | |
| Secondary | Number of patients with regression in esophageal varices in both groups. | 3 Months | |
| Secondary | Number of patients with improvement in Liver severity scores in both groups. | 28 days | |
| Secondary | Number of patients with improvement in Liver severity scores in both groups. | 60 days | |
| Secondary | Number of patients with improvement in Liver severity scores in both groups. | 3 months | |
| Secondary | Number of patients with development of adverse events in both groups in both groups. | 28 days | |
| Secondary | Number of patients with development of adverse events in both groups in both groups. | 2 months | |
| Secondary | Number of patients with development of adverse events in both groups in both groups. | 3 Months |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 31541422 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02583698
GET https://conductscience.org/api/trials/v1/NCT02583698/registered